Rheumatology International

, Volume 28, Issue 7, pp 685–691

Polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase genes: a study on fibromyalgia susceptibility

  • Berna Tander
  • Sezgin Gunes
  • Omer Boke
  • Gamze Alayli
  • Nurten Kara
  • Hasan Bagci
  • Ferhan Canturk
Original Article

Abstract

Genetic and environmental factors are thought to play roles in the etiopathology of fibromyalgia syndrome (FMS). The objective of this study was to determine the potential effects of single nucleotide polymorphisms (SNPs) in catechol-O-methyltransferase (COMT) (rs4680) and 5-hydroxytryptamine (serotonin) 2A (5-HT2A) receptor (rs6313 and rs6311) genes on susceptibility to FMS. One hundred seventy-one women (80 FMS, 91 control) were enrolled in the study. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for the genotyping analyses. Genotype and allele frequencies were calculated by the chi-square test. Beck depression inventory, state and trait anxiety inventory and symptom checklist-90 revised (SCL-90-R) tests were applied to both patients and controls. There were no observed differences in the frequencies of alleles and genotypes between patients and controls for the COMT, and the two 5-HT2A receptor gene polymorphisms (P > 0.05). Our results suggest that the investigated polymorphisms seem not to be the susceptibility factors in etiology of FMS.

Keywords

Fibromyalgia Gene polymorphism 102T/C 5-HT2A −1438G/A 

References

  1. 1.
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172PubMedCrossRefGoogle Scholar
  2. 2.
    Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMedCrossRefGoogle Scholar
  3. 3.
    Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, Kuck J, Leslie V, Masur D, Wagner M, Waid R, Zisook S (1999) Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40:57–63PubMedGoogle Scholar
  4. 4.
    Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV (2006) Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67(8):1219–1225PubMedCrossRefGoogle Scholar
  5. 5.
    Buskila D, Sarzi-Puttini P (2006) Biology and therapy of fibromyalgia.Genetic aspects of fibromyalgia syndrome. Arthritis Res Ther 8(5):218PubMedCrossRefGoogle Scholar
  6. 6.
    Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, Starck LO, Keck PE Jr (2004) Family study of fibromyalgia. Arthritis Rheum 50:944–952PubMedCrossRefGoogle Scholar
  7. 7.
    Buskila D, Neumann L, Hazanov I, Carmi R (1996) Familial aggregation in the fibromyalgia syndrome. Semin Arthritis Rheum 26:605–611PubMedCrossRefGoogle Scholar
  8. 8.
    Gürsoy S, Erdal E, Herken H, Madenci E, Alasehirli B (2001) Association of T102C polymorphism of the 5HT2A receptor gene with pyschiatric status in fibromyalgia syndrome. Rheumatol Int 21(2):58–61PubMedCrossRefGoogle Scholar
  9. 9.
    Gürsoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N (2003) Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 23(3):104–107PubMedGoogle Scholar
  10. 10.
    Buskila D, Cohen H, Neumann L, Ebstein RP (2004) An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Mol Psychiatry 9(8):730–731PubMedCrossRefGoogle Scholar
  11. 11.
    Su SY, Chen JJ, Lai CC, Chen CM, Tsai FJ (2007) The association between fibromyalgia and polymorphism of monoamine oxidase A and interleukin-4. Clin Rheumatol 26(1):12–16PubMedCrossRefGoogle Scholar
  12. 12.
    Graeff FG (1997) Serotoninergic systems. Psychiatr Clin North Am 20:723–739PubMedCrossRefGoogle Scholar
  13. 13.
    Tokunaga A, Saika M, Senba E (1998) 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery. Pain 76:349–355PubMedCrossRefGoogle Scholar
  14. 14.
    Fuentes JA, Lauzurica N, Hurtado A, Escartí A, Barrios V, Morande G, Soriano J, Jauregui I, Gonzalez-Valdemoro MI, Garcia-Camba E (2004) Analysis of the −1438 G/A polymorphism of the 5-HT2A serotonin receptor gene in bulimia nervosa patients with or without a history of anorexia nervosa. Psychiatr Genet 14(2):107–109PubMedCrossRefGoogle Scholar
  15. 15.
    Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW. (1998) Evidence for association between polymorphism in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine. Mol Psychiatry 3:61–66PubMedCrossRefGoogle Scholar
  16. 16.
    Williams J, Spurlock G, McGuffin P, Mallet J, Nöthen MM, Gill M, Aschauer H, Nylander PO, Macciardi F, Owen MJ (1996) Association between schizophrenia and T102C polymorphism of the 5-hydroxytrytamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 347:1294–1296PubMedGoogle Scholar
  17. 17.
    Seretti A, Cusin C, Lattuada E, Di Bella D, Catalano M, Smeraldi E (1999) Serotonin transporter gene (5-HTTLPR) is not associated with depressive symptomatology in mood disorders. Mol Psychiatry 4:280–283PubMedCrossRefGoogle Scholar
  18. 18.
    Bondy B, Spaeth M, Offenbaecher M, Glatzeder K, Stratz T, Schwarz M, de Jonge S, Krüger M, Engel RR, Färber L, Pongratz DE, Ackenheil M (1999) The T102C polymorphism of the 5-HT2A-receptor gen in fibromyalgia. Neurobiol Dis 6:433–439PubMedCrossRefGoogle Scholar
  19. 19.
    Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Krüger M, Schoeps P, Ackenheil M (1999) Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42(11):2482–488PubMedCrossRefGoogle Scholar
  20. 20.
    Enoch MA, Goldman D, Barnett R, Sher L, Mazzanti CM, Rosenthal NE (1999) Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, −1438G/A. Mol Psychiatry 4:89–92PubMedCrossRefGoogle Scholar
  21. 21.
    Tot S, Erdal E, Yazici K, Yazici AE, Metin O (2003) T102C and −1438 G/A polymorphisms of the receptor gene in Turkish patients with obsessive-compulsive disorder. Eur Psychiatry 18:249–254PubMedCrossRefGoogle Scholar
  22. 22.
    Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6(3):243–250PubMedCrossRefGoogle Scholar
  23. 23.
    Erdal ME, Tot S, Yazici K, Yazici A, Herken H, Erdem P, Derici E, Camdeviren H (2003) Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety 18(1):41–45PubMedCrossRefGoogle Scholar
  24. 24.
    Sazci A, Ergul E, Kucukali I, Kilic G, Kaya G, Kara I (2004) Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Brain Res Mol Brain Res 132(1):51–56PubMedCrossRefGoogle Scholar
  25. 25.
    Hudson JI, Arnold LM, Keck PE, Auchenbach MB, Pope HG (2004) Family study of fibromyalgia and affective spectrum disorder. Biol Psychiatry 56:884–891PubMedCrossRefGoogle Scholar
  26. 26.
    Ackenheil M (1998) Genetics and pathopsiology of affective disorders: relationship to fibromyalgia. Z Rheumatol 57(2):5–7PubMedCrossRefGoogle Scholar
  27. 27.
    Buskila D (2007) Genetics of chronic pain states. Best Pract Res Clin Rheumatol 21(3):535–547PubMedCrossRefGoogle Scholar
  28. 28.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. The American Psychiatric Association, Washington, DCGoogle Scholar
  29. 29.
    Derogatis LR (1977) SCL-90-R administration scoring and procedures manual-I for the revised version. Johns Hopkins University School of Medicine, BaltimoreGoogle Scholar
  30. 30.
    Dağ İ (1991) Belirti Tarama Listesi SCL-90-R’nin üniversite öğrencileri için güvenirliği geçerliği. Türk Psikiyatri Dergisi 2:5–12Google Scholar
  31. 31.
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedGoogle Scholar
  32. 32.
    Hisli N (1988) The reliability and validity study of the Beck Depression Inventory in a Turkish sample. Psikoloji Dergisi 6:118–122 (in Turkish)Google Scholar
  33. 33.
    Spielberger CD, Gorsuch RL, Lusahene RE (1970) Manual for stait-trait anxiety inventory. California Consulting Psychologist Press, Palo AltoGoogle Scholar
  34. 34.
    Ozer AK (1994) Sürekli Öfke ve öfke ifade tarzı ölçekleri ön çalışması. Türk Psikoloji Dergisi 31:26–35Google Scholar
  35. 35.
    Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18(5):728–733PubMedGoogle Scholar
  36. 36.
    Sarmer S, Ergin S, Yavuzer G (2000) The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire. Rheumatol Int 20(1):9–12PubMedCrossRefGoogle Scholar
  37. 37.
    Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215PubMedCrossRefGoogle Scholar
  38. 38.
    National Center for Biotechnology Information LocusLink Database. http://www.ncbi.nih.gov/LocusLink
  39. 39.
    Cohen H, Buskila D, Neumann L, Ebstein RP (2002) Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5-HTTLPR) polymorphism, and the relationship to anxiety related personality traits. Arthritis Rheum 46(3):845–847PubMedCrossRefGoogle Scholar
  40. 40.
    Frank B, Niesler B, Bondy B, Späth M, Pongratz DE, Ackenheil M, Fischer C, Rappold G (2004) Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients. Clin Rheumatol 23:338–344PubMedCrossRefGoogle Scholar
  41. 41.
    Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243PubMedCrossRefGoogle Scholar
  42. 42.
    Gürsoy S (2002) Absence of association of the serotonin transporter gene polymorphism with mentally healthy subset of fibromyalgia patients. Clin Rheumatol 21:194–197PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Berna Tander
    • 1
  • Sezgin Gunes
    • 2
  • Omer Boke
    • 3
  • Gamze Alayli
    • 1
  • Nurten Kara
    • 2
  • Hasan Bagci
    • 2
  • Ferhan Canturk
    • 1
  1. 1.Department of Physical Medicine and RehabilitationOndokuzmayis University School of MedicineKurupelitTurkey
  2. 2.Department of Medical Biology and GeneticsSchool of Medicine, Ondokuzmayis UniversitySamsunTurkey
  3. 3.Department of PsychiatrySchool of Medicine, Ondokuzmayis UniversitySamsunTurkey

Personalised recommendations